Home LiteratureArticle Details
PMID: 16823516 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Effect of extracellular ATP on the human leukaemic cell line K562 and its multidrug counterpart.

Molecular and cellular biochemistry ·Vol. 289 ·No. 1-2 ·2006-09-00 ·Pages 111-24

Bernardo AA, Pinto-Silva FE, Persechini PM, Coutinho-Silva R, Meyer-Fernandes JR, de Souza AL, Rumjanek VM

Abstract

Extracellular ATP (ATPo) is capable of inducing different events on cells through receptor activation. The effect produced by ATPo was studied in the cell line K562 and its multidrug resistant (MDR) counterpart, Lucena 1. Lower ATPo concentrations (1 mM and 2.5 mM) led to high (3)H-thymidine incorporation but no increase in cell number. Similarly, the cell cycle profile indicated an increase of cells in S phase and a decrease in G1 and G2, suggesting that the cells did not duplicate their DNA content. Higher doses of ATP (5 mM and 10 mM), as well as UTP (5 mM) and the P2X(7) agonist BzATP, were cytotoxic. However, no expression of P2X(7) receptors could be detected by Western Blot nor were the cells permeabilised by ATP, suggesting that pore formation was not involved in cell death. Both ecto-ATPase and ecto-5'-nucleotidase activity could be demonstrated at the surfaces of K562 and Lucena 1 cells, the latter presenting a higher ecto-5'-nucleotidase activity. Adenosine induced cell death at lower concentrations (2.5 mM) on both cell lines. Furthermore, an increased number of dead cells could be observed when 5 mM Adenosine was used compared to the same concentrations of ATPo. It still remains to be elucidated the nature of the receptors involved in the induction of cell death in these cells.

MeSH Terms
5'-Nucleotidase/metabolism ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism Adenosine/pharmacology Adenosine Triphosphatases/metabolism Adenosine Triphosphate/pharmacology Apoptosis/drug effects Apyrase/metabolism Cell Cycle/drug effects Cell Membrane Permeability/drug effects Cell Survival/drug effects Drug Resistance, Multiple/drug effects Humans K562 Cells Kinetics Phenotype Protein Binding/drug effects Purinergic P2 Receptor Agonists Purinergic P2 Receptor Antagonists Receptors, Purinergic P2X7 Thymidine/biosynthesis Tritium Tumor Cells, Cultured Uridine Triphosphate/pharmacology
Chemicals
ATP Binding Cassette Transporter, Subfamily B, Member 1 P2RX7 protein, human Purinergic P2 Receptor Agonists Purinergic P2 Receptor Antagonists Receptors, Purinergic P2X7 Tritium Adenosine Triphosphate 5'-Nucleotidase Adenosine Triphosphatases ectoATPase Apyrase Adenosine Uridine Triphosphate Thymidine
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Bernardo Alcira A
Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil.
Pinto-Silva Flavio Eduardo
Persechini Pedro M
Coutinho-Silva Robson
Meyer-Fernandes José Roberto
de Souza André Luiz Fonseca
Rumjanek Vivian M
References (39)
39 references, click to expand
  1. Nucleotide receptors: an emerging family of regulatory molecules in blood cells.
    Blood. 2001 Feb 1;97(3):587-600 PMID: 11157473
  2. The multidrug resistance (mdr1) gene product functions as an ATP channel.
    Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):312-6 PMID: 7678345
  3. Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase.
    Biochem Pharmacol. 2004 May 15;67(10):2005-11 PMID: 15130776
  4. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells.
    Am J Physiol. 1999 May;276(5 Pt 1):C1139-47 PMID: 10329963
  5. ATP, a partial agonist for the P2Z receptor of human lymphocytes.
    Br J Pharmacol. 1997 Nov;122(5):911-7 PMID: 9384508
  6. Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance.
    Int J Cancer. 1996 Nov 15;68(4):493-500 PMID: 8945621
  7. Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin.
    Int J Cancer. 1994 Oct 1;59(1):83-93 PMID: 7927909
  8. Extracellular ATP shows synergistic enhancement of DNA synthesis when combined with agents that are active in wound healing or as neurotransmitters.
    Biochem Biophys Res Commun. 1990 Jan 15;166(1):251-8 PMID: 1967937
  9. P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells.
    Am J Physiol. 1997 Dec;273(6 Pt 1):C1793-800 PMID: 9435482
  10. Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis.
    J Auton Nerv Syst. 2000 Jul 3;81(1-3):200-4 PMID: 10869721
  11. P2 receptor-mediated proliferative effects on astrocytes in vivo.
    Glia. 1999 Dec;28(3):190-200 PMID: 10559778
  12. Receptors for purines and pyrimidines.
    Pharmacol Rev. 1998 Sep;50(3):413-92 PMID: 9755289
  13. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor.
    J Biol Chem. 1999 Nov 19;274(47):33206-8 PMID: 10559192
  14. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
    Neurosci Lett. 1998 Feb 20;242(3):159-62 PMID: 9530930
  15. Extracellular ATP in the lymphohematopoietic system: P2Z purinoceptors off membrane permeabilization.
    Braz J Med Biol Res. 1998 Jan;31(1):25-34 PMID: 9686176
  16. Purines and their roles in apoptosis.
    Neuropharmacology. 1997 Sep;36(9):1149-56 PMID: 9364470
  17. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate.
    Int J Colorectal Dis. 2001 Jun;16(3):154-66 PMID: 11459289
  18. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP.
    Arterioscler Thromb Vasc Biol. 2000 Sep;20(9):2064-9 PMID: 10978250
  19. A contribution of the mitochondrial adenosinetriphosphatase inhibitor protein to the thermal stability of the F0F1-ATPase complex.
    Z Naturforsch C. 1997 Jul-Aug;52(7-8):459-65 PMID: 9309877
  20. ATP induces proliferation of retinal cells in culture via activation of PKC and extracellular signal-regulated kinase cascade.
    Int J Dev Neurosci. 2002 Feb;20(1):21-7 PMID: 12008071
  21. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.
    J Immunol Methods. 1983 Dec 16;65(1-2):55-63 PMID: 6606682
  22. P-glycoprotein in adult hematologic malignancies.
    Hematol Oncol Clin North Am. 1995 Apr;9(2):239-49 PMID: 7642463
  23. Differential assembly of rat purinergic P2X7 receptor in immune cells of the brain and periphery.
    J Biol Chem. 2001 Jun 29;276(26):23262-7 PMID: 11313357
  24. P-glycoprotein: from genomics to mechanism.
    Oncogene. 2003 Oct 20;22(47):7468-85 PMID: 14576852
  25. Involvement of P2 purinoceptors in the regulation of DNA synthesis in the neural retina of chick embryo.
    Int J Dev Neurosci. 1999 Apr;17(2):135-44 PMID: 10221673
  26. The determination of inorganic phosphate in the presence of labile phosphate esters.
    J Biol Chem. 1946 Mar;162:421-8 PMID: 21018750
  27. Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.
    An Acad Bras Cienc. 2001 Mar;73(1):57-69 PMID: 11246270
  28. Cellular distribution and functions of P2 receptor subtypes in different systems.
    Int Rev Cytol. 2004;240:31-304 PMID: 15548415
  29. The ATP4- receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions.
    Arch Biochem Biophys. 1992 Feb 1;292(2):411-8 PMID: 1370600
  30. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines.
    Cancer Res. 1993 Oct 15;53(20):4776-80 PMID: 8402660
  31. Adenosine-5'-triphosphate-(ATP) mediated stimulation and suppression of DNA synthesis in lymphoid cells. I. Characterization of ATP responsive cells in mouse lymphoid organs.
    J Immunol. 1981 Nov;127(5):1834-8 PMID: 7299116
  32. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.
    Biochim Biophys Acta. 1976 Nov 11;455(1):152-62 PMID: 990323
  33. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Toxicol Appl Pharmacol. 2005 May 1;204(3):216-37 PMID: 15845415
  34. Expression of P2X7 in human hematopoietic cell lines and leukemia patients.
    Leuk Res. 2004 Dec;28(12):1313-22 PMID: 15475073
  35. P2-pyrimidinergic receptors and their ligands.
    Curr Pharm Des. 2002;8(26):2353-69 PMID: 12369950
  36. Purinergic signalling: ATP release.
    Neurochem Res. 2001 Sep;26(8-9):959-69 PMID: 11699948
  37. ATP release via anion channels.
    Purinergic Signal. 2005 Dec;1(4):311-28 PMID: 18404516
  38. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).
    Science. 1996 May 3;272(5262):735-8 PMID: 8614837
  39. Molecular physiology of P2X receptors.
    Physiol Rev. 2002 Oct;82(4):1013-67 PMID: 12270951
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
Published
2006-09-00
Epub
2006-00-06
Pages
111-24
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com